Medicine News and Research

RSS

Combined technologies offer promise for detecting colon cancer in women

A team led by a Northwestern University biomedical engineer has found that combining novel optical technologies with a common colon cancer screening test may allow doctors to more accurately detect the presence of colon cancer, particularly in women.

20 Jul 2010

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Evansville (Ind.) Courier & Press reports on the struggles rural physicians face in providing care by focusing on Dr. Lloyd "Pat" McGinnis, a family medicine and geriatrics specialist who was "one of only five doctors in Spencer County, a rural area of Southwestern Indiana. … Doctors throughout the country are struggling with the same issues of providing quality care to patients with limited incomes in an environment of uncertainly as major provisions of the Patient Protection and Affordable Care Act are phased in over the next five years.

20 Jul 2010

Thymosin beta 4 improves neurological functional outcome after embolic stroke: Researchers

RegeneRx Biopharmaceuticals, Inc. today announced a research team from the Henry Ford Hospital in Detroit, MI, reported that Thymosin beta 4, administered to rats after embolic stroke, improved neurological functional outcome compared to control animals.

20 Jul 2010

Patients often receive inappropriate care when doctors fail to understand patient's situation: Study

Patients often receive inappropriate care when their doctors fail to take into account their individual circumstances, according to a new study by the University of Illinois at Chicago and the VA Center for Management of Complex Chronic Care.

20 Jul 2010

T-SPOT.TB test predicts TB infected persons better than TST: Study

The authors of a recent study published in the American Journal of Respiratory and Critical Care Medicine concluded that the T-SPOT.TB test is better than the tuberculin skin test at predicting which patients will develop active TB.

20 Jul 2010

Arthroscopic hip surgery may help athletes resume their sport back: Study

Hip problems can sideline even the best athletes, but a new study led by orthopedic experts from Rush University Medical Center indicates that the use of minimally invasive arthroscopic surgery to treat painful disorders of the hip may give athletes who undergo the procedure another opportunity to resume their sport back at their pre-injury level of competition.

20 Jul 2010

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Abbott today presented 48-week findings comparing an HIV regimen of its protease inhibitor (PI), Kaletra® (lopinavir/ritonavir), and Merck's integrase inhibitor, Isentress® (raltegravir), to a traditional HIV regimen of Kaletra and the nucleotide/nucleoside reverse transcriptase inhibitors (NRTIs) in Truvada® (tenofovir and emtricitabine) in antiretroviral-naive adult patients. Efficacy data were collected over the first 48 weeks of the 96-week PROGRESS (PROtease/InteGRasE Simplification Study) study.

20 Jul 2010

Lots of water breaks prevent dehydration in kids

Scorching heat has taken its toll across the country this summer with record temperatures and heat indexes reaching well above 100 degrees. Add kids playing outside and outdoor summer activities in full swing to the dangerous heat you've got a hazardous combination.

20 Jul 2010

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Kidney disease is a growing public health problem, with approximately half a million individuals in the United States requiring dialysis treatments to replace the function of their failed kidneys. The problem is particularly acute among African-Americans, whose rates of kidney disease are four times higher than those of European Americans.

20 Jul 2010

Practice nurses increase GP short consultations

The increased role of nurses in general practice is the primary driver of recent increases in short GP consultations, a general practice researcher from the School of Public Health says.

19 Jul 2010

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

IBA Dosimetry, member of IBA Group, will showcase its latest innovation in radiation therapy commissioning solutions, the Blue Phantom[2] water phantom equipped with advanced Linear Diode Array technology (LDA-99SC), at the American Association of Physicists in Medicine Annual Meeting in Philadelphia, July 18 - 22, 2010.

19 Jul 2010

ThermoGenesis anticipates $7.3 million revenue for fourth-quarter 2010

ThermoGenesis Corp., a leading supplier of innovative products and services that process and store adult stem cells, said today it expects revenues for the quarter ended June 30, 2010, to be approximately $7.3 million and to report a small net loss for the quarter, in the range of $150,000 to $450,000, subject to final audit adjustments. The Company plans to report complete final results for the fourth quarter and all of fiscal 2010 and provide its outlook for fiscal 2011 in mid-September.

19 Jul 2010

Today's OpEds: Public opinion and health reform; Hospitals and cost cuts; Medicare fraud 'gusher'

Less than four months after Congress approved historic health care reform legislation, the Obama administration has been making good progress in bringing some early benefits to fruition and issuing rules to guide the reform process. Despite all of the critics' hype and scare tactics, some polls suggest that the public perception of reform is slowly improving (7/18).

19 Jul 2010

Microarrays acquired from Vanderbilt University

Microarrays, Inc. (MI), an innovator of array-based technologies for biological research, detection and diagnostics, today announced that the company's management team and a group of independent investors have purchased MI from Vanderbilt University. The new company structure will allow MI to more quickly and nimbly respond to client's rapidly expanding needs, especially within the diagnostic and health care arenas.

19 Jul 2010

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.

From Novo Nordisk 19 Jul 2010

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

ViroStatics, a US/Italian biopharmaceutical company developing innovative immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data from a randomized, dose-ranging trial of VS411, the Company's novel combination product for treating HIV/AIDS, during the XVII International AIDS Conference this week in Vienna, Austria.

19 Jul 2010

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

FIT Biotech, a privately held biotechnology company developing novel, proprietary immunotherapies for HIV/AIDS and other viral diseases, announced results today from a Phase II clinical trial. The company's immunomodulator FIT-06 showed unprecedented long-term reductions in viral load (approximately 0.5 log) and statistically significant CD4 cell count increases in HIV-infected, previously untreated patients. The effect lasted longer than two years in the absence of any anti-retroviral therapy.

19 Jul 2010

Study evaluates immunization benefits of dissolving microneedles

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines - while providing improved immunization against diseases such as influenza.

19 Jul 2010

Three different methods for accurately measuring breast density

Two new studies announced this week have tested three different methods for accurately measuring breast density -- the relative portion of tissue to fat in a woman's breasts and a strong indicator of breast cancer risk.

19 Jul 2010

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.

19 Jul 2010

Medicine News and Research

Combined technologies offer promise for detecting colon cancer in women

Responding to access-to-care challenges: Ideas from a rural doctor, a Washington, D.C. hospital

Thymosin beta 4 improves neurological functional outcome after embolic stroke: Researchers

Patients often receive inappropriate care when doctors fail to understand patient's situation: Study

T-SPOT.TB test predicts TB infected persons better than TST: Study

Arthroscopic hip surgery may help athletes resume their sport back: Study

Abbott presents 48-week PROGRESS study results at 28th International AIDS Conference

Lots of water breaks prevent dehydration in kids

Researchers discover genetic explanation for non-diabetic kidney disease in African-Americans

Practice nurses increase GP short consultations

IBA Dosimetry to showcase Blue Phantom[2] radiation therapy commissioning solution with LDA-99SC at AAPM

ThermoGenesis anticipates $7.3 million revenue for fourth-quarter 2010

Today's OpEds: Public opinion and health reform; Hospitals and cost cuts; Medicare fraud 'gusher'

Microarrays acquired from Vanderbilt University

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

Study evaluates immunization benefits of dissolving microneedles

Three different methods for accurately measuring breast density

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News